ÂÜÀòÂÒÂ×

Christina Krill is a seasoned professional in the field of biotechnology, currently serving as the Manager of Molecular Lab Scaling & Sustaining at Adaptive Biotechnologies Corp. since June 2015, where Christina manages high complexity operational improvement projects and leads cross-functional laboratory scaling and validation initiatives. Prior experience includes roles as a Laboratory Technical Supervisor at Adaptive Biotechnologies, where Christina contributed to the validation of the FDA-approved product clonoSEQ, and an Independent Contractor at Pacific Biomarkers, where Christina specialized in clinical immunoassays. Earlier in their career, Christina held positions at Amgen, focusing on the development and validation of immunoassays for biotherapeutics, and at Merck, where Christina developed vaccine potency assays. Christina holds a Bachelor of Science in Biological Sciences from the University of Notre Dame and a Master of Science in Cell Biology and Biotechnology from the University of the Sciences in Philadelphia.